TY - CHAP M1 - Book, Section TI - Diabetes Mellitus A1 - Masharani, Umesh A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. A2 - McQuaid, Kenneth R. PY - 2022 T2 - Current Medical Diagnosis & Treatment 2022 AB - Key Clinical Updates in Diabetes MellitusDapagliflozin reduced the risk of end-stage kidney disease or death from renal and cardiovascular causes in a 2020 multinational study of 4304 patients with chronic kidney disease.The drug was safe and beneficial in patients with eGFR as low as 25 mL/min/1.73 m2.A third of the patients in the study did not have diabetes and had benefit. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/content.aspx?aid=1184162513 ER -